A study has found that the drugs that are commonly used to treat dementia might not help in treating people considered to be close to developing the condition.
The study, led by Dr. Raschetti at Italy's National Centre for Epidemiology, Surveillance and Health Promotion in Rome, concluded that cholinesterase inhibitors do not seem to delay the appearance of Alzheimer disease or other forms of dementia.
World Alzheimer's Day - 'No Time to Lose'
September 21st, 2007 is celebrated worldwide as World Alzheimer's Day. The theme for this year is 'No Time to Lose'.
Advertisement
Three cholinesterase inhibitors - donepezil, rivastigmine and galantamine - are currently approved for use in mild-to-moderate Alzheimer disease.
In the study, a systematic review of the data from clinical trials that had addressed the use of cholinesterase inhibitors with MCI patients was conducted.
![Controversy Over Use of Antipsychotic Drugs for Dementia]( "Controversy Over Use of Antipsychotic Drugs for Dementia")
Antipsychotic drugs are approved mainly for treating schizophrenia and bipolar disorder, but they are also used for many other purposes.
In none of the six trials that the team examined did the use of the drugs significantly reduce the rate of progression from MCI to dementia.
Some experts are not convinced that the inhibitors are effective, but other experts and patient support groups have called for the drugs to be given to people with 'mild cognitive impairment (MCI)'.
MCI is used to describe the condition where people have memory problems that are more severe than those normally seen in others of their age, but otherwise have no symptoms of dementia. It is believed that people with MCI are at high risk of developing Alzheimer disease.
Source: ANI
LIN/P
Controversy Over Use of Antipsychotic Drugs for Dementia
Antipsychotic drugs are approved mainly for treating schizophrenia and bipolar disorder, but they are also used for many other purposes.
Advertisement
In none of the six trials that the team examined did the use of the drugs significantly reduce the rate of progression from MCI to dementia.
Some experts are not convinced that the inhibitors are effective, but other experts and patient support groups have called for the drugs to be given to people with 'mild cognitive impairment (MCI)'.
MCI is used to describe the condition where people have memory problems that are more severe than those normally seen in others of their age, but otherwise have no symptoms of dementia. It is believed that people with MCI are at high risk of developing Alzheimer disease.
Source: ANI
LIN/P
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Dengue News
In April, the WHO issued a warning that climate change could trigger a worldwide surge in mosquito-borne diseases, including dengue, Zika, and Chikungunya.
Over the last 24 hours, there has been a notable increase in dengue patients, surpassing the total number of cases in Bihar, which now exceeds 13,000.
Dengue fever outbreak in Lucknow: The cumulative count of dengue cases in Lucknow has now reached 1,308.
Dengue Cases in Kolkata: The number surpasses the 1,102 cases reported in the preceding week. The total cases for the current season have now reached 7,422.
The dengue situation in Bengal has reached a critical stage, with the number of cases exceeding the 50,000 mark.